Scientific references

The following references are linked only by the posts written in September of 2013.

The other blog posts on this website have their own references each in the end of the article.

1. Gyurcsovics K, Bertók L. Pathophysiology of psoriasis: coping endotoxins with bile acid therapy. Pathophysiology. 2003 Dec;10(1):57-61.

2. Prawitt J, Caron S, Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes.

Curr Diab Rep. 2011 Jun;11(3):160-6.

3. Staels B, Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus.

Drugs. 2007;67(10):1383-92.

4. Iversen OJ. The expression of retrovirus-like particles in psoriasis. J Invest Dermatol. 1990 Nov;95(5):41S-43S.

5. Munz OH, Sela S, Baker BS, Griffiths CE, Powles AV, Fry L. Evidence for the presence of bacteria in the blood of psoriasis patients. Arch Dermatol Res. 2010 Sep;302(7):495-8.

6. Zhao G, Feng X, Na A, Yongqiang J, Cai Q, Kong J, Ma H. Acute guttate psoriasis patients have positive streptococcus hemolyticus throat cultures and elevated antistreptococcal M6 protein titers. J Dermatol. 2005 Feb;32(2):91-6.

7. Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992 Jan;128(1):39-42.

8. Ahlehoff O, Gislason GH, Lindhardsen J, Charlot MG, Jørgensen CH, Olesen JB, Bretler DM, Skov L, Torp-Pedersen C, Hansen PR. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS One. 2011 Mar 25;6(3):e18125.

9. Dipali P. Kadam, Adinath N. Suryakar, Rajesh D. Ankush, Charushila Y. Kadam, and Kishor H. Deshpande Role of Oxidative Stress in Various Stages of Psoriasis. Indian J Clin Biochem. 2010 October; 25(4): 388–392.

10. Khardikova SA, Beloborodova ÉI. Clinical and functional disorders of the stomach-in patients with psoriasis in the presence of chronic opisthorchiasis. Med Parazitol (Mosk). 2011 Apr-Jun;(2):22-5.

11. Andrew C. Dukowicz, MD, Brian E. Lacy, PhD, MD,corresponding author and Gary M. Levine, MD. Small Intestinal Bacterial Overgrowth. Gastroenterol Hepatol (N Y). 2007 February; 3(2): 112–122.

12. R Utili, CO Abernathy, HJ Zimmerman. Cholestatic effects of Escherichia coli endotoxin endotoxin on the isolated perfused rat liver. Volume 70, Issue 2 , Pages 248-253, February 1976

13. KENNETH B. SEAMON, WILLIAM PADGETT, AND JOHN W. DALY. Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Vol.78, No.6, pp.3363-3367, June 1981

14. Geraldine O. Canny and Beth A. McCormick. Bacteria in the Intestine, Helpful Residents or Enemies from Within? Infect. Immun. August 2008 vol. 76 no. 8 3360-3373


16. Haynes WG, Strachan FE, Webb DJ. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 1995 Aug 1;92(3):357-63.

17. Hai Lee Chung, Sang Gyung Kim, Im Hee Shin. The relationship between serum endothelin (ET)-1 and wheezing status in the children with Mycoplasma pneumoniae pneumonia. Pediatric Allergy and Immunology Volume 17, Issue 4, pages 285–290, June 2006

18. Su Y, Wen H, Zhan G, Zou Z, Li Y. Plasma and skin tissue endothelin in patients with psoriasis vulgaris. Hunan Yi Ke Da Xue Xue Bao. 1997;22(6):530-2.

19. Bonifati C, Mussi A, Carducci M, Pittarello A, D’Auria L, Venuti A, Bagnato A, Salani D, Fazio M, Ameglio F. Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol. 1998 Jan;78(1):22-6.

20. Said N, Smith S, Sanchez-Carbayo M, Theodorescu D. Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. J Clin Invest. 2011 Jan;121(1):132-47.


22. Boehncke S, Thaci D, Beschmann H, Ludwig RJ, Ackermann H, Badenhoop K, Boehncke WH. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007 Dec;157(6):1249-51.

23. Ksenia Tonyushkina, M.D. and James H. Nichols, Ph.D., DABCC, FACB. Glucose Meters: A Review of Technical Challenges to Obtaining Accurate Results. J Diabetes Sci Technol. 2009 July; 3(4): 971–980.


25. García-Montoya IA, Cendón TS, Arévalo-Gallegos S, Rascón-Cruz Q. Lactoferrin a multiple bioactive protein: an overview. Biochim Biophys Acta. 2012 Mar;1820(3):226-36.

26. Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: a critical overview.

Cell Mol Life Sci. 2005 Nov;62(22):2540-8.





31. Owen JS, Brown DJ, Harry DS, McIntyre N, Beaven GH, Isenberg H, Gratzer WB. Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins.

J Clin Invest. 1985 Dec;76(6):2275-85.



34. Qayoom S, Ahmad QM. Psoriasis and Helicobacter pylori. Indian J Dermatol Venereol Leprol. 2003 Mar-Apr;69(2):133-4.


36. Cloarec D, Gouilloud S, Bornet F, Bruley des Varannes S, Bizais Y, Galmiche JP. Lactase deficiency and lactose intolerance-related symptoms in adult healthy subjects from western France. Gastroenterol Clin Biol. 1991;15(8-9):588-93.





41. Adkins DR, Abidi MH, Brown RA, Khoury H, Goodnough LT, Vij R, Westervelt P, DiPersio JF. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. Bone Marrow Transplant. 2000 Dec;26(11):1239-41.

42. Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, Bergman J, Brooks PM, Biggs JC. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum. 1998 Mar;41(3):453-9.

43. Snowden J.A., Heaton D.C. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br. J. Dermatol. 1997;137:130-132.

44. Kopel E, Levi A, Harari M, Ruzicka T, Ingber A. Effect of the Dead Sea climatotherapy for psoriasis on quality of life. Isr Med Assoc J. 2013 Feb;15(2):99-102.

45. Butler G, Michaels JC, Al-Waili N, Finkelstein M, Allen M, Petrillo R, Carrey Z, Kolanuvada B, Lee BY, Riera AG, Michaels CC, Urteaga G. Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature. J Med Case Rep. 2009 Aug 10;3:7023.

46. Bertók L. Bile acids in physico-chemical host defence. Pathophysiology. 2004 Dec;11(3):139-145.


48. Doulat Rai Bajaj, Shah Muhammad Mahesar, Muhammad Hanif Ghani. Hemoglobin content and sedimentation properties of erythrocytes in psoriasis. Journal of Pakistan Association of Dermatologists 2008; 18: 132-137.

49. Sung Yul Lee, Hong Kyu Lee, Jung Youl Lee, Jong Suk Lee. Analyses of Serum Zinc and Copper Levels in Psoriasis. Korean Journal of Investigative Dermatology 1996; Vol 3, No. 1, pp. 35-38

50. NACI M. BOR, A. KARABIYIKOGLU, H. DEREAGZI. ZINC IN TREATMENT OF PSORIASIS. Journal of Islamic Academy of Sciences 4:1, 78-82, 1991

51. Xu SUN, Xiaodong ZHANG, Hui HU, Yina LU, Jie CHEN, Kazuki YASUDA, and Heyao WANG. Berberine Inhibits Hepatic Stellate Cell Proliferation and Prevents

Experimental Liver Fibrosis Biol. Pharm. Bull. 32(9) 1533—1537 (2009)

52. Gregory S. Kelly, ND. Nutritional and Botanical Interventions to Assist with the Adaptation to Stress. Alternative Medicine Review, Volume 4, Number 4, 1999

53. Atsuo Sakurai, Nobuo Okahashi, Ichiro Nakagawa, Shigetada Kawabata, Atsuo Amano, Takashi Ooshima, and Shigeyuki Hamada. Streptococcus pyogenes Infection Induces Septic Arthritis with Increased Production of the Receptor Activator of the NF-kB Ligand. INFECTION AND IMMUNITY, Oct. 2003, p. 6019–6026

54. Saeed Changizi Ashtiyani, Houshang Najafi, Kobra Kabirinia, Ellham Vahedi, Leila Jamebozorky. Oral Omega-3 Fatty Acid for Reduction of Kidney Dysfunction Induced by Reperfusion Injury in Rats. IJKD 2012;6:275-83

55. Satu Vesterlund, Matti Karp, Seppo Salminen and Arthur C. Ouwehand. Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology (2006), 152, 1819–1826

56. L.O.Simpson and D.J.O’Neill. Red Blood Cell Shapes in Women with Fibromyalgia and the Implications for Capillary Blood Flow and Tissue Function. Journal of Orthomolecular Medicine Vol. 16, No. 4, 2001

57. Jonathan E. Prousky, B.P.H.E., B.Sc., N.D. Is Vitamin B3 Dependency a Causal Factor in the Development of Hypochlorhydria and Achlorhydria? Journal of Orthomolecular Medicine Vol. 16, No. 4, 2001

58. John T. A. Ely, Ph.D. Hypochlorhydria and Multiple Organ Failure: A Leading Cause of Death in the Intensive Care Unit. Journal of Orthomolecular Medicine Vol. 19, No. 1, 2004

59. Ozlem Karabudak, Rifat Eralp Ulusoy, Alev Akyol Erikci, Emrullah Solmazgul, Bilal Dogan and Yavuz Harmanyeri. Inflammation and Hypercoagulable State in Adult Psoriatic Men. Acta Derm Venereol 2008; 88: 337–340

60. Nayma Sultana, Noorzahan Begum, Shelina Begum, Sultana Ferdousi, Taskina Ali. Effects of Oral Supplementation of Vitamin E on Fragility of RBC in Hemolytic Anemic Patients with G6PD Deficiency. BSMMU J 2008; 1(1): 6-10

61. F. Z. Zangeneh, A. Fazeli. THE SIGNIFICANCE OF STRESS HORMONES IN PSORIASIS. Acta Medica Iranica, Vol. 46, No. 6 (2008)

62. Peter G. Sohnle, M.D., Charles H. Kirkpatrick, M.D. Epidermal Proliferation in the Defense Against Experimental Cutaneous Candidasis. The Journal of Investigative Dermatology. 70:130-133, 1978

63. C-H. VON BONSDORFF, ELLI JANSSON, U. VAINIO, AND SIRKKA TUURI. Ultrastructure of a mycoplasma recovered from the bone marrow in systemic lupus erythematosus. Ann. rheum. Dis. (1973), 32, 25

64. Edemilson Cardoso da Conceiçao, M.S., Tadao Shuhama, Ph.D., Clarice Izumi, Ph.D., Osvaldo de Freitas, Ph.D. Iron supplementation prevents the development of iron deficiency in rats with omeprazole-induced hypochlorhydria. Nutrition Research 21 (2001) 1201–1208

65. JOHN G. GILMAN and GEORGE J. BREWER. The Oxygen-Linked Zinc-Binding Site of Human Haemoglobin Biochem. J. (1978) 169, 625-632

66. By Ray Yip, Narla Mohandas, Margaret R. Clark, Sushil Jam, Stephen B. Shohet, and Peter R. Dallman. Red Cell Membrane Stiffness in Iron Deficiency. Blood, Vol. 62, No. 1 (July), 1983: pp. 99-106

67. Ernest Beutler. G6PD Deficiency. Blood, Vol 84, No 11 (December l), 1994 pp 3613-3636

68. Silvio Balzan, Claudio de Almeida Quadros, Roberto de Cleva, Bruno Zilberstein and Ivan Cecconello. Bacterial translocation: Overview of mechanisms and

clinical impact. Journal of Gastroenterology and Hepatology 22 (2007) 464–471

69. M. J. HILL AND B. S. DRASAR. Degradation of bile salts by human intestinal bacteria. Gut, 1968, 9, 22-27

70. Alan R. Gaby, MD. Helicobacter pylori Eradication: Are there Alternatives to Antibiotics? Alternative Meidcine Review Volume 6, Number 4, 2001

71. Gregory S. Kelly, N.D. Hydrochloric Acid: Physiological Functions and Clinical Implications. Alt Med Rev 1997; 2(2):116-127

72. Weed, R. I., and B. Chailley. 1972. Calcium-pH interactions in the production of shape change in erythrocytes. Nouv. Rev. Fr. Hematol. 12:775-788.

73. White, J. G. 1974. Effects of an ionophore, A23187, on the surface morphology of normal erythrocytes. Am. J. Pathol. 77:507-518.

74. Nakao, M., T. Nakao, S. Yamazoe, and H. Yoshikawa. 1961. Adenosine triphosphate and shape of erythrocytes. J. Biochem. 49:487-492.

75. Allan, D., and R. H. Michell. 1975. Accumulation of 1,2-diacylglycerol in the plasma membrane may lead to echinocyte transformation of erythrocytes. Nature (London) 258:348-349.

76. Geraldine O. Canny and Beth A. McCormick. Bacteria in the Intestine, Helpful Residents or Enemies from Within? Infect. Immun. 2008, 76(8):3360.

77. Janne Prawitt, Sandrine Caron, Bart Staels. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 2011 June; 11(3): 160–166.

78. J. SCHMITT-SLOMSKA, E. SACQUET, R. CARAVANO. Group A Streptococcal L Forms – I. Persistence Among Inoculated Mice. JOURNAL OF BACTERIOLOGY, Jan., 1967, p. 451-455

79. BETTY J. MILLS, ROBERT D. LINDEMAN AND CALVIN A. LANG. Effect of Zinc Deficiency on Blood Glutathione Levels. J. Nutr. Ill: 1098-1102, 1981.

80. L. T. KOCSAR, L. BERTOK, AND V. VARTERESZ. Effect of Bile Acids on the Intestinal Absorption of Endotoxin in Rats. JOURNAL OF BACTERIOLOGY, Oct. 1969, p. 220-223


82. Stella Kourembanas, Philip A. Marsden, Lynda P. McQuillan, and Douglas V. Faller. Hypoxia Induces Endothelin Gene Expression and Secretion in Cultured Human Endothelium. J. Clin. Invest. 1991. 88:1054-1057.

83. Hossein-nezhad A, Spira A, Holick MF (2013). Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial. PLoS ONE 8(3): e58725.

84. Skaar EP (2010). The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts. PLoS Pathog 6(8): e1000949.

85. A. Sanchis, M. Sancho, G. Martínez , J.L. Sebastián and S. Muñoz. Electromagnetic radiofrequency fields and red blood cell aggregation.

86. Christina S. Faherty and Anthony T. Maurelli. Staying alive: bacterial inhibition of

apoptosis during infection. Trends in Microbiology Vol.16 No.4 18 March 2008


88. SHMUEL RAZIN, DAVID YOGEV, AND YEHUDITH NAOT. Molecular Biology and Pathogenicity of Mycoplasmas. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, Dec. 1998, p. 1094–1156

89. PAMELA J. FRAKER, PAULA DEPASQUALE-JARDIEU, CRAIG M. ZWICKL, AND RICHARD W. LUECKE. Regeneration of T-cell helper function in zinc-deficient adult mice. Proc. Nati. Acad. Sci. USA Vol. 75, No. 11, pp. 5660-5664, November 1978

90. KENNETH B. SEAMON, WILLIAM PADGETT, AND JOHN W. DALY. Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. NatL Acad. Sci. USA

Vol. 78, No. 6, pp. 3363-3367, June 1981

91. Takeshi Inagaki, Antonio Moschetta, Youn-Kyoung Lee, Li Peng, Guixiang Zhao, Michael Downes, Ruth T. Yu, John M. Shelton, James A. Richardson, Joyce J. Repa, David J. Mangelsdorf, and Steven A. Kliewe. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. 3920–3925, PNAS March 7, 2006 vol. 103 no. 10

92. J. H. LAWRIE, M.B.Glasg., F.R.C.S., F.R.C.S.E., D.C.H. A. P. M. FORREST, M.D., Ch.M., B.Sc., (St. And.), F.R.C.S., F.R.C.S.E., F.R.C.S. (Glasg.). THE MEASUREMENT OF GASTRIC ACID. POSTGRAD. MED. J. (1965), 41, 408

93. Dr D N Croft. Body Iron Loss and Cell Loss from Epithelia. Proc. roy. Soc. Med. Volume 63 December 1970

94. W. Neuhofer and D. Pittrow Endothelin in human autoimmune diseases with renal involvement. Rheumatology 2006;45:iii39–iii41

95. Manuel Sánchez Regaña, MD. TOPICAL VITAMIN B12: EVALUATION OF ITS EFFICACY IN PLAQUE-TYPE PSORIASIS. Revista Latinoamericana de Psoriasis y Artritis Psoriásica 2011, 3: 15-24

96. J. Richard Allison, M.D. The Relation of Hydrochloric Acid and Vitamin B Complex Deficiency in Certain Skin Diseases. Southern Medical Journal April 1945 Vol. 38 No. 4

97. B. Brett Finlay, and Grant McFadden Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens. Cell 124, 767–782, February 24, 2006

98. Appelberg R. Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol. 2007 Feb;15(2):87-92.

99. Gilman RH, Partanen R, Brown KH, Spira WM, Khanam S, Greenberg B, Bloom SR, Ali A. Decreased gastric acid secretion and bacterial colonization of the stomach in severely malnourished Bangladeshi children. Gastroenterology. 1988 Jun;94(6):1308-14.


101. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000 Jan;43(1):103-8.

102. Segal R, Lubart E, Leibovitz A, Berkovitch M, Habot B, Yaron M, Caspi D. Early and late effects of low-dose aspirin on renal function in elderly patients. Am J Med. 2003 Oct 15;115(6):462-6.

103. Segal R, Lubart E, Leibovitz A, Iaina A, Caspi D. Renal effects of low dose aspirin in elderly patients. Isr Med Assoc J. 2006 Oct;8(10):679-82.

104. G Antsaklis, M R Lewin, D J Sutor, A G Cowie, and C G Clark. Gallbladder function, cholesterol stones, and bile composition. Gut. 1975 December; 16(12): 937–942.

105. DANIEL L. SWAGERTY, JR., M.D., M.P.H., ANNE D. WALLING, M.D., and ROBERT M. KLEIN, PH.D. Lactose Intolerance Am Fam Physician. 2002 May 1;65(9):1845-1851.


107. Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol. 2001 May;7(2):73-7.


109. Mikako Obika and Hirofumi Noguchi. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease. Experimental Diabetes Research Volume 2012 (2012), Article ID 145754, 12 pages

110. Yong-Jian Zhou, Yu-Yuan Li, Yu-Qiang Nie, Jin-Xiang Ma, Lun-Gen Lu, Sheng-Li Shi, Min-Hu Chen, Pin-Jin Hu. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007 December 21; 13(47): 6419-6424

111. Christopher D. Williams, Joel Stengel, Michael I. Asike, Dawn M. Torres, Janet Shaw, Maricela Contreras, Cristy L. Landt, Stephen A. Harrison. Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study. Gastroenterology Volume 140, Issue 1 , Pages 124-131, January 2011

112. Deepak Amarapurkar, Prafull Kamani, Nikhil Patel, Parijat Gupte, Pravin Kumar, Subhash Agal, Rajiv Baijal, Somesh Lala, Dinesh Chaudhary, Anjali Deshpande. Prevalence of non-alcoholic fatty liver disease: population based study. Annals of Hepatology 2007; 6(3): July-September: 161-163


114.M. Teresa Satué-Gracia, Edwin N. Frankel, Nagendra Rangavajhyala, and J. Bruce German. Lactoferrin in Infant Formulas:  Effect on Oxidation. J. Agric. Food Chem., 2000, 48 (10), pp 4984–4990

115. BETH A. CHOBY, MD. Diagnosis and Treatment of Streptococcal Pharyngitis. Am Fam Physician. 2009 Mar 1;79(5):383-390.

116.RIAL D. ROLFE, DAVID J. HENTGES, BENEDICT J. CAMPBELL, AND JAMES T. BARRETT. Factors Related to the Oxygen Tolerance of Anaerobic Bacteria. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Aug. 1978, p. 306-313

117. Klemp P, Staberg B. Cutaneous blood flow in psoriasis. J Invest Dermatol. 1983 Dec;81(6):503-6.

118. Klemp P. Local regulation of cutaneous blood flow in psoriasis. J Invest Dermatol. 1984 Dec;83(6):421-5.

119. Klemp P. Regulation of local subcutaneous blood flow in patients with psoriasis and effects of antipsoriatic treatment on subcutaneous blood flow. J Invest Dermatol. 1985 Aug;85(2):175-8.

120. Klemp P, Bojsen J. Local variation in cutaneous and subcutaneous blood flow measured by CdTe(C1) minidetectors in normal and psoriatic skin. J Invest Dermatol. 1986 Feb;86(2):109-14.

121. Cicalese L, Sahai A, Sileri P, Rastellini C, Subbotin V, Ford H, Lee K. Acute pancreatitis and bacterial translocation. Dig Dis Sci. 2001 May;46(5):1127-32.

122. Marsh PD. Dental plaque as a microbial biofilm. Caries Res. 2004 May-Jun;38(3):204-11.

123. Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J Dent Res. 2009 Nov;88(11):982-90.

124. Soudah HC, Lu Y, Hasler WL, Owyang C. Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol. 1992 Jul;263(1 Pt 1):G102-7.

125. Lillian G. Dawes, M.D., Joseph P. Muldoon, M.D., Mary Anne Greiner, Marco Bertolotti, M.D. Cholecystokinin Increases Bile Acid Synthesis with Total Parenteral Nutrition but Does Not Prevent Stone Formation. Journal of Surgical Research Volume 67, Issue 1, January 1997, Pages 84–89

126. Busscher HJ, Rinastiti M, Siswomihardjo W, van der Mei HC. Biofilm formation on dental restorative and implant materials. J Dent Res. 2010 Jul;89(7):657-65.

127. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000 Feb;190(3):255-66.

128. Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol. 2009 Jun;90(3):232-48.

129. Grace K. Kim, DO and James Q. Del Rosso, DO. Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated? J. Clin Aesthet Dermatol. 2010 January; 3(1): 32–38.

130. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005 Aug;52(8):2513-8.

131.  Jeana Blalock and Jafa Armagost, Dr. Guy Caldwell, Ph.D, Dr. Kim Caldwell, Ph.D. Bacterial Neurotoxicity and Parkinson’s Disease.

132. Collins MA, Neafsey EJ. Potential neurotoxic “agents provocateurs” in Parkinson’s disease. Neurotoxicol Teratol. 2002 Sep-Oct;24(5):571-7.

133. Vilhjalmur Ari Arason, Clinical Associate Professor and Johann A. Sigurdsson, Professor. The problems of antibiotic overuse. Scand J Prim Health Care. 2010; 28(2): 65–66.

134. Mahmoud H. Ayesh, Khaled Jadalah, Eiman Al Awadi, Khaldoon Alawneh, Basheer Khassawneh. Association between vitamin B12 level and anti-parietal cells and anti-intrinsic factor antibodies among adult Jordanian patients with Helicobacter pylori infection. The Brazilian Journal of Infectious Diseases, Available online 6 June 2013

135. Hsia CH, Shen MC, Lin JS, Wen YK, Hwang KL, Cham TM, Yang NC. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res. 2009 Mar;29(3):190-6.

136. Fujita M, Hong K, Ito Y, Fujii R, Kariya K, Nishimuro S. Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol Pharm Bull. 1995 Oct;18(10):1387-91.


138. C Badet and N.B Thebaud. Ecology of Lactobacilli in the Oral Cavity: A Review of Literature. Open Microbiol J. 2008; 2: 38–48.

139. Maria del Carmen Ahumada, Elena Bru, Maria Eugenia Colloca, Maria Elena López and Maria Elena Nader-Macías. Evaluation and comparison of lactobacilli characteristics in the mouths of patients with or without cavities. Journal of Oral Science, Vol. 45, No. 1, 1-9, 2003

140. Lu Q, Luo SX, Wu H, Mo CM, Luo R N Y. Liver Regeneration in the first week after Living Donor Liver Transplantation: Evaluation with Sonography. Hepatogastroenterology. 2013 Aug;60(126):1307-10.

141. Haga J, Shimazu M, Wakabayashi G, Tanabe M, Kawachi S, Fuchimoto Y, Hoshino K, Morikawa Y, Kitajima M, Kitagawa Y. Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl. 2008 Dec;14(12):1718-24.

142. Bhakdi S, Bayley H, Valeva A, Walev I, Walker B, Kehoe M, Palmer M. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol. 1996 Feb;165(2):73-9.

143. Yun Wu and F. Wayne Outten. IscR Controls Iron-Dependent Biofilm Formation in Escherichia coli by Regulating Type I Fimbria Expression. J. Bacteriol. February 2009 vol. 191 no. 4 1248-1257

144. SHERSTEN KILLIP, M.D., M.P.H., JOHN M. BENNETT, M.D., M.P.H., and MARA D. CHAMBERS, M.D. Iron Deficiency Anemia Am Fam Physician. 2007 Mar 1;75(5):671-678.

145. M. J. HILL. Action of Bile Salts on Bacterial Cell Walls. Nature 214, 1152 – 1154 (10 June 1967)

146. Máire Begley, Cormac G.M. Gahan, Colin Hill. The interaction between bacteria and bile. FEMS Microbiology Reviews 29 (2005) 625–651

147. Eva Untersmayr, MD and Erika Jensen-Jarolim, MD. The role of protein digestibility and antacids on food allergy outcomes. J. Allergy Clin Immunol. 2008 June; 121(6): 1301–1310.


149. Arianna Carughi, Liem T Huynh and Dalia Perelman. Effect of omega-3 fatty acid supplementation on indicators of membrane fluidity. FASEB J. April 2010 24 (Meeting Abstract Supplement) 939.12

150. Mijna Hadders-Algra. Effect of Long-Chain Polyunsaturated Fatty Acid Supplementation on Neurodevelopmental Outcome in Full-Term Infants Nutrients. 2010 August; 2(8): 790–804.

151. Holan G, Fuks AB. The diagnostic value of coronal dark-gray discoloration in primary teeth following traumatic injuries. Pediatr Dent. 1996 May-Jun;18(3):224-7.

152. Cardoso M, de Carvalho Rocha MJ. Association of crown discoloration and pulp status in traumatized primary teeth. Dent Traumatol. 2010 Oct;26(5):413-6.

153. Mikhail Peslyak. Model of pathogenesis of psoriasis. Part 1. Systemic psoriatic process. 2009-2012 p.42-46

154. Jiang T, Savaiano DA. In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation. J Nutr. 1997 Aug;127(8):1489-95.

155. Bin Gao, Won-Il Jeong, and Zhigang Tian Liver: An Organ with Predominant Innate Immunity HEPATOLOGY, February 2008 p.729-736

156. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev. 2000 Apr;174:21-34.

157. Lequette Y, Boels G, Clarisse M, Faille C. Using enzymes to remove biofilms of bacterial isolates sampled in the food-industry. Biofouling. 2010 May;26(4):421-31.

158. Tets VV, Knorring GIu, Artemenko NK, Zaslavskaia NV, Artemenko KL. Impact of exogenic proteolytic enzymes on bacteria Antibiot Khimioter. 2004;49(12):9-13.

159. Park Y, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med. 2011 Jun 27;171(12):1061-8.

160. Xiaojing Li, Kristin M. Kolltveit, Leif Tronstad, and Ingar Olsen. Systemic Diseases Caused by Oral Infection Clin. Microbiol. Rev. October 2000 vol. 13 no. 4 547-558


162. Melissa B. Rogers. Mycoplasma and cancer: in search of the link Oncotarget. 2011 April; 2(4): 271–273.

163. T K Chan, D Todd, and S C Tso. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency. Br Med J. 1976 November 20; 2(6046): 1227–1229.

164. Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf. 2010 Sep 1;33(9):713-26.

165. Wajcman H, Galactéros F. Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents. C R Biol. 2004 Aug;327(8):711-20.

166. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol. 2011 Jul 1;187(1):490-500.

167. W M Castleden, P Detchon, and N L Misso. Biliary bile acids in cholelithiasis and colon cancer. Gut. 1989 June; 30(6): 860–865.

168. B. Scott Appleton & T. Colin Campbell. Inhibition of aflatoxin-initiated preneoplastic liver lesions by low dietary protein. Nutrition and Cancer, Volume 3, Issue 4, 1981


170. Carol Bernstein, Hana Holubec, Achyut K. Bhattacharyya, Huy Nguyen, Claire M. Payne, Beryl Zaitlin, and Harris Bernstein. Carcinogenicity of deoxycholate, a secondary bile acid Arch Toxicol. 2011 August; 85(8): 863–871.

171. Daniel R. Schmidt, Sam R. Holmstrom, Klementina Fon Tacer, Angie L. Bookout, Steven A. Kliewer and avid J. Mangelsdorf. Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D. J Biol Chem. 2010 May 7;285(19):14486-94.

172. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002 May 17;296(5571):1313-6.

173. Han S, Chiang JY. Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos. 2009 Mar;37(3):469-78.

174. Pereira F, Larriba MJ, Muñoz A. Vitamin D and colon cancer. Endocr Relat Cancer. 2012 May 3;19(3):R51-71.

175. Jamie A. Nehring, Claudia Zierold, and Hector F. DeLuca. Lithocholic acid can carry out in vivo functions of vitamin D. PNAS June 12, 2007, vol. 104, no. 24 10006-10009.

176. González-Sancho JM, Larriba MJ, Ordóñez-Morán P, Pálmer HG, Muñoz A. Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res. 2006 Jul-Aug;26(4A):2669-81.

177. Tabaqchali, S, and Booth, C C. (1966). Jejunal bactenology and bile-salt metabolism in patients with intestinal malabsorption. Lancet, 2, 12-15.

178. Hatzioannou, J., and Booth, C. C. (1968). Bile-salt deconjugation and steatorrhoea in patients with

the stagnant-loop syndrome. Ibid., 2, 12-16.

179. Dawson, A. M., and Isselbacher, K. J. (1960). Studies on lipid metabolism in the small intestine with observations on the role of bile salts. J. clin. Invest., 39, 730-740.

180. Heaton, K. W., and Read, A. E. (1969). Gallstones in patients with disorders of the terminal ileum and disturbed bile salt metabolism. Brit. med. J., 3, 494-496.

181. DENNIS STAMP AND GARETH JENKINS. An Overview of Bile-Acid Synthesis, Chemistry and Function.

182. Setchell KD, Heubi JE, Shah S, Lavine JE, Suskind D, Al-Edreesi M, Potter C, Russell DW, O’Connell NC, Wolfe B, Jha P, Zhang W, Bove KE, Knisely AS, Hofmann AF, Rosenthal P, Bull LN. Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology. 2013 May;144(5):945-955.e6; quiz e14-5.

183. Gruy-Kapral C, Little KH, Fordtran JS, Meziere TL, Hagey LR, Hofmann AF. Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology. 1999 Jan;116(1):15-21.

184. García Rodríguez L. A., Duque A., Castellsague J., Pérez-Gutthann S. & Stricker B. H. C. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol 1999; 48(6): 847-852.

185. Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D (May 1983). Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J. Clin. Invest. 71 (5): 1495–9.

186. Hans M. G. Princen, Chritdne M. G. Huijsmans, Folkert Kuipers, Roel J. Vonk, and Herman Jan M. Kempen. Ketoconazole Blocks Bile Acid Synthesis in Hepatocyte Monolayer Cultures and In Vivo in Rat by Inhibiting Cholesterol 7a-Hydroxylase. J. Clin. Invest. Volume 78, October 1986, 1064-1071


188. J. Petrek, L. Havel, J. Petrlova, V. Adam, D. Potesil, P. Babula, R. Kizek. Analysis of salicylic acid in willow barks and branches by an electrochemical method. Russian Journal of Plant Physiology, July 2007, Volume 54, Issue 4, pp 553-558

189. Penneys NS, Ziboh V, Simon P, Lord J. Pathogenesis of Woronoff ring in psoriasis. Arch Dermatol. 1976 Jul;112(7):955-7.

190. Neisius U, Olsson R, Rukwied R, Lischetzki G, Schmelz M. Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J. Am Acad Dermatol. 2002 Jul;47(1):28-32.

191. Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, Lin HC. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004 Apr;63(4):450-2.

192. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol. 2002 Nov 15;34(3):209-14.

193. Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann N Y Acad Sci. 2009 Sep;1173:757-65.

194. Lüscher EF. Activation of the blood coagulation system during gram-negative infections and endotoxemias. Fortschr Med. 1975 Aug 14;93(22-23):1072-6.

195. Kastrup CJ, Boedicker JQ, Pomerantsev AP, Moayeri M, Bian Y, Pompano RR, Kline TR, Sylvestre P, Shen F, Leppla SH, Tang WJ, Ismagilov RF. Spatial localization of bacteria controls coagulation of human blood by ‘quorum acting’. Nat Chem Biol. 2008 Dec;4(12):742-50.

196. Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992 Jan;128(1):39-42.

197. Zhao G, Feng X, Na A, Yongqiang J, Cai Q, Kong J, Ma H. Acute guttate psoriasis patients have positive streptococcus hemolyticus throat cultures and elevated antistreptococcal M6 protein titers. J. Dermatol. 2005 Feb;32(2):91-6.

198. Villeda-Gabriel G, Santamaría-Cogollos LC, Pérez-Lorenzo R, Reyes-Maldonado E, Saúl A, Jurado-Santacruz F, Jiménez-Zamudio L, García-Latorre E. Recognition of Streptococcus pyogenes and skin autoantigens in guttate psoriasis. Arch Med Res. 1998 Summer; 29(2):143-8.

199. Song Z, Borgwardt L, Høiby N, Wu H, Sørensen TS, Borgwardt A. Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms. Orthop Rev (Pavia). 2013 Jun 14;5(2):65-71.

200. Rodney M. Donlan. Biofilms and Device-Associated Infections. Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001

201. Che YM, Mao SH, Jiao WL, Fu ZY. Susceptibilities of Mycoplasma hominis to herbs. Am. J. Chin Med. 2005;33(2):191-6.

202. Chen X, Mellon RD, Yang L, Dong H, Oppenheim JJ, Howard OM. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants. Biochem Pharmacol. 2002 Feb 1;63(3):533-41.

203. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on

renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000 Jan;43


204. Radosavljevic T, Mladenovic D, Vucevic D, Vukicevic RJ. The role of oxidative/nitrosative

stress in pathogenesis of paracetamol-induced toxic hepatitis. Med Pregl. 2010 Nov-Dec;63


205. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos. 2003 Dec;31(12):1499-506.

206. Rabia Bushra and Nousheen Aslam. An Overview of Clinical Pharmacology of Ibuprofen. Oman Med J. 2010 July; 25(3): 155–1661.




210. Sakurai A, Maruyama F, Funao J, Nozawa T, Aikawa C, Okahashi N, Shintani S, Hamada S,
Ooshima T, Nakagawa I. Specific behavior of intracellular Streptococcus pyogenes that has
undergone autophagic degradation is associated with bacterial streptolysin O and host small
G proteins Rab5 and Rab7. J Biol Chem. 2010 Jul 16;285(29):22666-75.

211. Yoshimori T, Amano A. Group A Streptococcus: a loser in the battle with autophagy. Curr Top Microbiol Immunol. 2009;335:217-26.

212. Fischetti, V. A.;Novick, R. P.;Ferretti, J. J.;Portnoy, D. A.;Rood, J. I. Intracellular invasion by Streptococcus pyogenes: invasins, host receptors, and relevance to human disease. Gram-positive pathogens 2006 pp. 29-36